Impact News +++ AptarGroup übertrifft Gewinnprognose für Q3 2025, Aktie bricht dennoch ein (Investing.com DE) +++ APTARGROUP Aktie -3,16%

RESMED Aktie

>RESMED Aktienkurs

209.5 EUR -1.8% (Tradegate)

Ask: 211.5 EUR / 240 Stück

Bid: 209.6 EUR / 240 Stück

Tagesumsatz: 164 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

RESMED Aktie über LYNX handeln

Intraday

1 Jahr

>RESMED Performance

1 Woche: -4,5%

1 Monat: -8,5%

3 Monate: -11,5%

6 Monate: +3,3%

1 Jahr: -4,3%

laufendes Jahr: -3,7%

>RESMED Aktie

Name:

RESMED INC. DL-,004

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US7611521078 / 895878

Symbol/ Ticker:

RME (Frankfurt) / RMD (NYSE)

Kürzel:

FRA:RME, ETR:RME, RME:GR, NYSE:RMD

Index:

S&P500

Webseite:

https://investor.resmed.c..

Profil:

ResMed Inc. is an innovative leader in the develop..
>Volltext..

Marktkapitalisierung:

31979.72 Mio. EUR

Unternehmenswert:

31664.25 Mio. EUR

Umsatz:

4446.44 Mio. EUR

EBITDA:

1661.65 Mio. EUR

Nettogewinn:

1210.23 Mio. EUR

Gewinn je Aktie:

8.25 EUR

Schulden:

735.97 Mio. EUR

Liquide Mittel:

1044.97 Mio. EUR

Operativer Cashflow:

1513.38 Mio. EUR

Bargeldquote:

1.2

Umsatzwachstum:

-0.13%

Gewinnwachstum:

24.75%

Dividende je Aktie:

1.88 EUR

Dividendenrendite:

0.86%

Dividendenschätzung:

0.95%

Div. Historie:

14.08.25 - 0.5148€
08.05.25 - 0.45473996€

>weitere anzeigen...

Insiderhandel:

3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.115.848 USD.

Suchwörter:

RESMED

Letzte Datenerhebung:

31.10.25

>RESMED Kennzahlen

Aktien/ Unternehmen:

Aktien: 145.94 Mio. St.

Frei handelbar: 99.37%

Leerverk. Aktien: 6.14%

Rückkaufquote: 0.61%

Mitarbeiter: 10600

Umsatz/Mitarb.: 0.42 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 19.1%

Bewertung:

KGV: 27.02

KGV lG: 23.27

KUV: 7.34

KBV: 6.3

PEG-Ratio: 0.72

EV/EBITDA: 19.06

Rentabilität:

Bruttomarge: 58.48%

Gewinnmarge: 27.22%

Operative Marge: 32.79%

Managementeffizenz:

Gesamtkaprendite: 18.62%

Eigenkaprendite: 25.86%

>RESMED Peer Group

Es sind 596 Aktien bekannt.

>RESMED Chart & Kurs - NYSE

>RESMED News

31.10.25 - 15:00	Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand (Zacks)
	RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence....

31.10.25 - 13:48	ResMed declares $0.60 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.25 - 03:21	ResMed outlines high single-digit growth targets for mask segment as new fabric mask launches drive innovation (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.25 - 01:48	Why Cedar Woods, Newmont, ResMed, and Titomic shares are pushing higher today (Fool)
	It has been a happy Halloween for owners of these shares. But why? The post Why Cedar Woods, Newmont, ResMed, and Titomic shares are pushing higher today appeared first on The Motley Fool Australia....

31.10.25 - 00:12	ResMed shares charge higher on strong Q1 update (Fool)
	This sleep disorder treatment company delivered more strong growth during the three months. The post ResMed shares charge higher on strong Q1 update appeared first on The Motley Fool Australia....

31.10.25 - 00:00	Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

30.10.25 - 23:12	Resmed Inc Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) announced a profit for its third quarter that Increased from last year and beat the Street estimates.The company's earnings totaled $348.5 million, or $2......

30.10.25 - 21:12	ResMed Non-GAAP EPS of $2.55 beats by $0.05, revenue of $1.3B misses by $30M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 17:15	Do Options Traders Know Something About ResMed Stock We Don′t? (Zacks)
	Investors need to pay close attention to RMD stock based on the movements in the options market lately....

23.10.25 - 17:30	ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
	ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

21.10.25 - 15:45	What 9 Analyst Ratings Have To Say About ResMed (Benzinga)
	Latest Ratings for RMD DateFirmActionFromTo Jan 2022CitigroupUpgradesNeutralBuy Jan 2022RBC CapitalUpgradesUnderperformSector Perform Jan 2022JP MorganUpgradesNeutralOverweight View More Analyst Ratings for RMD View the Latest Analyst Ratings read more...

20.10.25 - 20:30	Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren (Zacks)
	Zacks highlights four GARP (Growth at a Reasonable Price) stocks Stryker, NVIDIA, ResMed, and Ralph Lauren combining strong growth prospects with attractive valuations for maximum returns....

13.10.25 - 13:30	Zacks.com featured highlights include ResMed, Safran, Pentair, Casey′s and Leonardo (Zacks)
	Amid market uncertainty, low-leverage stocks RMD, SAFRY, PNR, CASY, and DRS emerge as safer investment options for steady growth....

13.10.25 - 10:09	Corporate News: Fractus (EQS)
	Fractus reicht im südlichen Bezirk von Kalifornien Klage wegen Patentverletzung gegen ResMed ein...

13.10.25 - 10:09	Corporate News: Fractus (EQS)
	Fractus files patent infringement complaint against ResMed in the Southern District of California...

13.10.25 - 10:06	Fractus files patent infringement complaint against ResMed in the Southern District of California (PR Newswire)
	Action seeks to protect Fractus' pioneering antenna inventions used in connected sleep apnea therapies/devices BARCELONA, Spain, Oct. 13, 2025 /PRNewswire/ -- Fractus, a pioneer in geometry-based antenna technology and IP licensing, today announced that it has filed a patent infringement......

09.10.25 - 22:09

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 (GlobeNewswire EN)

SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast....

09.10.25 - 20:01	Insiderhandel: Chief Executive Officer verkauft Aktien von ResMed im Wert von 2265332 USD (Insiderkauf)
	Farrell, Michael J. - Vorstand - Tag der Transaktion: 2025-10-07...

07.10.25 - 14:12	What to Expect From ResMeds Next Quarterly Earnings Report (Barchart)
	ResMed is expected to release its fiscal first-quarter earnings soon, and analysts project a double-digit earnings growth....

07.10.25 - 00:24	Buy, hold, sell: ResMed, Sonic Healthcare, and Steadfast (Fool)
	Let's see what analysts are saying about these popular stocks. The post Buy, hold, sell: ResMed, Sonic Healthcare, and Steadfast appeared first on The Motley Fool Australia....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Lehrling hört mit Bangigkeit die sich kreuzenden Stimmen. Es scheint ihm jede Recht zu haben, und eine sonderbare Verwirrung bemächtigt sich seines Gemüts. - Novalis

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram